Review
doi: 10.1212/wnl.63.7_suppl_2.s23.
Clinical trials of neuroprotection for Parkinson's disease
Affiliations
- PMID: 15477583
- DOI: 10.1212/wnl.63.7_suppl_2.s23
Item in Clipboard
Review
Clinical trials of neuroprotection for Parkinson's disease
Neurology.
.
No abstract available
Similar articles
-
Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease.Neurology. 2004 Oct 12;63(7 Suppl 2):S13-22. doi: 10.1212/wnl.63.7_suppl_2.s13. Neurology. 2004. PMID: 15477581 Review. No abstract available.
-
Selegiline's neuroprotective capacity revisited.J Neural Transm (Vienna). 2003 Nov;110(11):1273-8. doi: 10.1007/s00702-003-0083-x. J Neural Transm (Vienna). 2003. PMID: 14628191 No abstract available.
-
A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.Neurology. 2004 Oct 12;63(7 Suppl 2):S32-5. doi: 10.1212/wnl.63.7_suppl_2.s32. Neurology. 2004. PMID: 15477584 Review. No abstract available.
-
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.Clin Ther. 2007 Sep;29(9):1825-49. doi: 10.1016/j.clinthera.2007.09.021. Clin Ther. 2007. PMID: 18035186 Review.
-
Reexamination of the TEMPO Study.Arch Neurol. 2005 Aug;62(8):1320; author reply 1321. doi: 10.1001/archneur.62.8.1320. Arch Neurol. 2005. PMID: 16087778 No abstract available.
Cited by
-
Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.CNS Drugs. 2011 Dec 1;25(12):1061-71. doi: 10.2165/11596310-000000000-00000. CNS Drugs. 2011. PMID: 22133327 Review.
-
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.Curr Neuropharmacol. 2006 Jan;4(1):69-75. doi: 10.2174/157015906775203039. Curr Neuropharmacol. 2006. PMID: 18615133 Free PMC article.
-
Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.J Neural Transm (Vienna). 2009 Nov;116(11):1457-72. doi: 10.1007/s00702-009-0225-x. Epub 2009 Apr 25. J Neural Transm (Vienna). 2009. PMID: 19396396
-
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.BMJ Open. 2019 Jun 9;9(6):e027770. doi: 10.1136/bmjopen-2018-027770. BMJ Open. 2019. PMID: 31182448 Free PMC article.
-
Behavioral effects of cocaine mediated by nitric oxide-GAPDH transcriptional signaling.Neuron. 2013 May 22;78(4):623-30. doi: 10.1016/j.neuron.2013.03.021. Neuron. 2013. PMID: 23719162 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
